USD 200 million to support WDF’s work over the next decade
Novo Nordisk's commitment will help WDF and its partners strengthen diabetes prevention and care in low- and middle-income countries, reaching more people in underserved communities.
The World Diabetes Foundation welcomes a USD 200 million commitment from Novo Nordisk over the next ten years to support our work on diabetes and other non-communicable diseases in communities with limited access to healthcare.
Announced during Diabetes Awareness Month, the commitment provides a long-term foundation for WDF to plan ahead, build on our partnerships and support locally led efforts to improve access to prevention and care.
“This will enable WDF and our many partners to continue working to improve prevention and equitable access to care for people in need,” says Leif Fenger Jensen, Managing Director of the World Diabetes Foundation.
Elin Jäger, Senior Vice President of CEO Office, Transformation & Sustainability at Novo, emphasises the importance of sustained support:
“They require long-term commitment, strong local partnerships and solutions that can become part of everyday healthcare. Through this ten-year commitment, we want to help the World Diabetes Foundation build on what works, strengthen local health systems and bring prevention and care within reach of more underserved communities,” she says, referring to lasting improvements in health.